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Abstract
Electrical stimulation of midbrain tectum structures, particularly the dorsal periaqueductal gray (dPAG) and inferior colliculus 
(IC), produces defensive responses, such as freezing and escape behavior. Freezing also ensues after termination of dPAG 
stimulation (post-stimulation freezing). These defensive reaction responses are critically mediated by γ-aminobutyric acid 
and 5-hydroxytryptamine mechanisms in the midbrain tectum. Neurokinins (NKs) also play a role in the mediation of dPAG 
stimulation-evoked fear, but how NK receptors are involved in the global processing and expression of fear at the level of the 
midbrain tectum is yet unclear. The present study investigated the role of NK-1 receptors in unconditioned defensive behav-
ior induced by electrical stimulation of the dPAG and IC of male Wistar rats. Spantide (100 pmol/0.2 μL), a selective NK-1 
antagonist, injected into these midbrain structures had anti-aversive effects on defensive responses and distress ultrasonic 
vocalizations induced by stimulation of the dPAG but not of the IC. Moreover, intra-dPAG injections of spantide did not influ-
ence post-stimulation freezing or alter exploratory behavior in rats subjected to the elevated plus maze. These results suggest 
that NK-1 receptors are mainly involved in the mediation of defensive behavior organized in the dPAG. Dorsal periaqueductal 
gray-evoked post-stimulation freezing was not affected by intra-dPAG injections of spantide, suggesting that NK-1-mediated 
mechanisms are only involved in the output mechanisms of defensive behavior and not involved in the processing of ascending 
aversive information from the dPAG.
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Electrical and chemical stimulation of the dorsal peri-
aqueductal gray (dPAG) and inferior colliculus (IC) causes 
a characteristic pattern of active defense reactions, which 
include alertness, freezing, escape responses, and auto-
nomic changes that resemble anxiety disorder (1,2). Much 
evidence has implicated γ-aminobutyric acid (GABA), 
5-hydroxytryptamine (5-HT), excitatory amino acids, nitric 
oxide, and opioids in the modulation of defense reactions in 
these midbrain tectum structures, but less is known about 
the involvement of neurokinin (NK)-mediated mechanisms 
in these responses (for a review, see Ref. 3). 
Substance P is widely distributed in the brain, including 
the amygdala, septum, hippocampus, and hypothalamus, 
and is involved in the regulation of affective behavior and 
the mediation of stress responses (4,5). Substance P has 
also been implicated in the mediation of fear in the dPAG 
(6,7). Local injections of substance P into this region elicit 
anxiety-like behavior in animals, including conditioned place 
aversion and a decrease in the time spent in the open arms 
of the elevated plus maze (EPM), a widely used animal 
model of anxiety (6-8). Substance P has been shown to 
be involved in stress-, depression-, and anxiety-related 
behaviors (9,10). Although the presence of substance P 
and NK receptors in the IC has been documented in the 
literature (11), to our knowledge, no study has investigated 
the possible role of NK-mediated mechanisms in the IC in 
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fear and anxiety.
The anxiogenic effects of substance P in the dPAG ap-
pear to be mediated by NK-1 receptors (6,8,12,13). NK-1 
receptor antagonists may be effective in the treatment of 
depression in patients with symptoms of anxiety, leading 
to research efforts aimed at the development of therapies 
for both depression and anxiety (9,14). The dPAG and IC 
are involved mainly in the output of defense reactions and 
processing of aversive information, respectively. Unknown, 
however, is the extent to which NK-1-mediated mechanisms 
regulate defense reactions in the dPAG and IC. Unraveling 
the role of NK-1-mediated mechanisms in the components 
of defensive behavior organized in the midbrain tectum will 
help shed light on the functions of the neural substrates of 
fear and anxiety. To approach this issue, we will consider 
several studies that have related each level of defense 
reactions, such as freezing, escape, and post-stimulation 
freezing (PSF), with each particular aversive state of the 
defense reaction. For example, freezing behavior induced 
by direct stimulation of the dPAG may be considered a 
preparatory response for escape, and the vigorous, undi-
rected flight elicited by proximal danger may be related to 
panic. PSF has been related to the processing of aversive 
information that is relayed to higher brain structures (3,15-
17). Here, we examined the effects of local injections of 
substance P and the NK-1 receptor antagonist spantide 
into midbrain structures on freezing, escape, and freezing-
evoked responses elicited by stimulation of the dPAG and 
IC in rats. In addition to these behavioral responses, dis-
tress ultrasonic vocalizations (USVs) were also recorded 
during these defensive responses. Several studies from 
this and other laboratories (18-20) have shown that USVs, 
especially those emitted in the range of 22-kHz, are an 
important emotional component of the defense reaction. 
The emission of this type of call is controlled in part by the 
dPAG, in which substance P-mediated mechanisms seem 
to play an important role (7,21).
Material and Methods
Animals
Male Wistar rats weighing 250-280 g, from the animal 
house of the Ribeirão Preto Campus, University of São 
Paulo, were used. They were transported to a local vivarium 
in the laboratory where they were housed in groups of 4 per 
cage (40 x 30 x 25 cm). The animals were maintained at 
constant temperature (22 ± 1°C) and on a 12-h/12-h light/
dark cycle (7:00 am-7:00 pm lights on). After surgery, they 
were group housed (3-5 rats per cage) in Plexiglas-walled 
cages with free access to food and water throughout the 
experiment. All experimental procedures were approved by 
the Committee for Animal Care and Use of the University 
of São Paulo, Ribeirão Preto Campus (No. 09.1.84.54.7). 
All efforts were made to minimize animal suffering and to 
reduce the number of animals used in the study.
Surgery
The animals were anesthetized with tribromoethanol 
(250 mg/kg, ip) and fixed in a stereotaxic frame (David 
Kopf, USA). The upper incisor bar was set 3.3 mm below 
the interaural line such that the skull was horizontal between 
bregma and lambda. A chemitrode made of a stainless 
steel guide cannula (0.6 mm in outer diameter, 0.4 mm in 
inner diameter) was glued to a brain electrode and aimed 
at the dPAG or IC. The electrode was made of a stainless 
steel wire (160 µm in diameter) insulated except at the 
cross-section. The electrode was introduced at a 16° angle 
toward the dPAG, with lambda serving as the reference 
for the following coordinates: anteroposterior (AP) = 0.1 
mm; mediolateral (ML) = 1.9 mm; dorsoventral (DV) = 5.2 
mm. For the IC, the following coordinates were used: AP 
= -0.8 mm; ML = 1.2 mm; DV = 5.0 mm. All coordinates 
were taken from the surface of the skull. For all groups, the 
electrodes and cannula were fixed to the skull using acrylic 
resin and two stainless steel screws. The electrode wire 
was connected to a male pin so that it could be plugged 
into an amphenol socket at the end of a flexible electrical 
cable and used for brain stimulation. At the end of surgery, 
each guide cannula was sealed with a stainless steel wire 
to protect it from obstruction.
Drugs
The NK-1 receptor antagonist spantide ([D-Arg1, D-
Trp7,9, Leu11]-substance P acetate salt) was obtained 
from Sigma (Brazil), dissolved and diluted to the desired 
concentration with phosphate-buffered saline (PBS), pH 7.4. 
Spantide was injected at the dose of 100 pmol/0.2 μL, which 
was chosen on the basis of previous studies (7,22).
The present study was divided into two experiments 
with independent groups of animals. The first experiment 
examined the effects of microinjections of spantide into the 
dPAG and IC on defense reactions induced by electrical 
stimulation of these regions. Ultrasonic vocalizations were 
simultaneously recorded during the expression of the de-
fense responses (freezing, escape and dPAG- or IC-evoked 
PSF) at baseline and after the drug treatments. In the second 
experiment, we assessed the effects of intra-dPAG injec-
tions of spantide on exploratory behavior in rats subjected 
to the EPM. The effects of injections of spantide into the IC 
were not examined in this part of the study because of the 
absence of effects in the preceding experiment.
Microinjection procedure
A total volume of 0.2 μL was used for the drug injections 
into the dPAG. Control animals received the same volume 
of vehicle. The injection needle was a thin dental needle 
(0.3 mm in outer diameter) connected to a 5-μL Hamilton 
syringe by means of a polyethylene tube. It was introduced 
through the guide cannula until its lower end was 1 mm 
below the guide cannula. The solutions were prepared 
shortly before use and injected into the dPAG (0.2 μL/min), 
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driven by an infusion pump (Harvard Apparatus, USA). The 
displacement of an air bubble inside the polyethylene-10 
tubing (Becton-Dickinson, USA) that connected the syringe 
needle to the intracerebral needle was used to monitor the 
microinjection. The needle was held in place for an additional 
1 min to maximize diffusion away from the needle tip. 
Experiment 1. Effects of spantide on aversive 
thresholds determined by electrical stimulation 
of the dPAG and IC
One week after surgery, the animals were placed in an 
experimental open field that consisted of a circular enclo-
sure (60 x 50 cm) made of transparent Plexiglas. The floor 
consisted of 15 stainless bars (2.0 mm in diameter) spaced 
12 mm apart. The animals were allowed a 5-min period of 
habituation to the box at the beginning of each session. 
Thereafter, the brain was stimulated electrically using a sine 
wave stimulator (Del Vecchio, Brazil). The stimulation cur-
rent was monitored by measuring the voltage drop across 
a 1 KΩ resistor with an oscilloscope (Philips, Brazil). Brain 
stimulation (alternating current, 60 Hz, 10 s) was presented 
at 1-min intervals with the current intensity increasing by 
5-µA steps to determine aversive thresholds.
The freezing threshold was operationally defined as 
the lowest intensity that produced an interruption of ongo-
ing behavior lasting more than 6 s and attentive postures 
toward the animals’ surroundings (23-25). The current 
intensity that produced running (galloping) or jumping in 
two successive trials was considered to be the escape 
threshold. These measures were confirmed in another 
consecutive ascending series of electrical stimulation. A 
cut-off intensity of 150 µA (peak-to-peak) was used for 
electrical stimulation. To investigate the behavioral effects 
of the electrical stimulation that triggered escape behavior, 
the animals remained in the experimental box for another 
5 min without any stimulation, during which time freezing 
behavior was recorded. This post-stimulation period is 
referred to as dPAG PSF (15,16).
After these baseline measurements, each animal was 
wrapped in a cloth, and a thin dental needle was introduced 
through the guide cannula until its lower end protruded 1 
mm below the guide cannula. The animals then received 
either PBS (N = 8) or spantide (N = 8). Ten minutes later, 
aversive thresholds and the time spent freezing after dPAG 
or IC stimulation were determined again. The drug dose 
and waiting time after the injections were selected from 
previous studies in this laboratory (7,22). 
Recording of ultrasound vocalizations
An Ultra Sound Gate Condenser Microphone (CM 
16) that is sensitive to 10-120-kHz frequencies with a flat 
frequency response between 15 and 30 kHz (± 6 dB) and 
between 40 and 70 kHz (± 12 dB) was connected to a 
computer via an Avisoft Ultrasound Gate 416 USB audio 
device (Avisoft Bioacoustics, Berlin, Germany) such that 
acoustic data were displayed on the computer in real time 
(Avisoft Recorder, Avisoft Bioacoustics) and recorded at a 
sampling rate of 214,285 Hz in 16-bit format. For acousti-
cal analysis, the recordings were transferred to SASLab 
Pro (versions 4.3 and 4.52; Avisoft Bioacoustics), and a 
fast Fourier transformation (FFT) was conducted (512 
FFT-length, 100% frame, Hamming window and 75% time 
window overlap). Spectrograms were produced with a 
488-Hz frequency resolution and 0.512-ms time resolution. 
The number of 22-kHz calls was automatically measured 
using an automatic threshold-based algorithm (55-33-dB 
threshold) and a hold-time mechanism (10-40-ms hold time). 
A lower cut-off frequency of 18 kHz was used to reduce 
background noise outside the relevant frequency band to 0 
dB. During each test session, the microphone was placed 
through a support in the middle of the top surface of the 
arena approximately 40 cm above the floor to record the 
entire spectrum of USVs. A video camera linked to a TV 
monitor was used to monitor global behavior during the 
entire recording period.
Experiment 2. Effects of spantide in the EPM
As a control for the preceding experiments, the effects 
of treatment with 100 pmol spantide on spontaneous explor-
atory activity were evaluated. For this purpose, additional 
groups of rats were tested individually in the EPM. The EPM 
was made of wood and had two open arms (50 x 10 cm) 
that were perpendicular to two closed arms of the same 
size with 50-cm high walls. The apparatus was elevated 
50 cm above the floor. To avoid falls, the open arms were 
surrounded by a 3-mm wooden rim. The apparatus was 
located inside a room with constant noise (50 dB). The 
behavior of the animals was recorded with a video camera 
(Everfocus, USA) positioned above the maze. The signal 
was relayed to a monitor in another room via a closed-circuit 
video camera, which allowed the identification of all forms 
of behavior. Luminosity at the level of the open arms of the 
EPM was 20 lux. The maze was cleaned thoroughly after 
each test with damp and dry cloths. Experimental sessions 
were conducted between 12:00 and 6:00 pm and lasted 5 
min. The rats were placed individually in the center of the 
EPM facing a closed arm. An observer trained to measure 
ethological EPM parameters subsequently scored the vid-
eotapes using the Observer analysis software developed 
by Noldus (Amsterdam, The Netherlands). We measured 
the number of entries into both arms and the time spent on 
different parts of the maze. An arm entry or exit was defined 
as all four paws entering into or exiting an arm, respectively. 
These data were used to calculate the percentage of open 
arm entries and percentage of time spent in the open arms. 
A detailed description of the use of the EPM in this labora-
tory can be found elsewhere (6-8).
Histology
After the completion of the experiments, the animals 
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received an overdose of urethane and were intracardially 
perfused with saline followed by 4% buffered formalin. 
Evans blue (2%) was then microinjected into the dPAG at the 
same volume as the drug microinjections to mark the drug 
injection sites. The brains were removed and maintained in 
formalin for 1 day and then maintained in 30% sucrose for 
another 3 days. Serial 60-μm brain sections were cut with 
a microtome, thaw-mounted on gelatin-coated slides, and 
Nissl-stained to identify the sites of the injections according 
to the atlas of Paxinos and Watson (26).
Statistical analysis
Data are reported as means ± SEM. In Experiment 
1, aversive threshold differences between pre- and post-
treatments and the duration of PSF were analyzed by the 
Student t-test. For the USV analyses, two-way analysis of 
variance (ANOVA, without repeated measures) was used to 
assess the effects of spantide and PBS injections into the 
dPAG and IC. Treatment (PBS or spantide) and condition 
(baseline and test) were the factors. In Experiment 2, the 
number of open and closed arm entries and the percentage 
of time spent in the open and closed arms relative to the 
total time of the EPM test were analyzed by the Student 
t-test. Differences between multiple means were assessed 
by the Bonferroni t-test. Values of P < 0.05 were considered 
to be statistically significant.
Results
As the intensity of the current applied to the dPAG and 
IC increased, the animals suddenly stopped their ongoing 
behavior, became immobile, and often urinated and def-
ecated. With higher intensities, this freezing behavior was 
followed by vigorous running and jumping. The electrode 
tips and injection sites were situated inside the dorsolateral 
and dorsomedial divisions of the PAG as well as inside the 
central nucleus of the IC. These sites were similar to those 
shown in previous papers published from this laboratory 
(6,7,15,16,25,27). Although the electrical stimulation applied 
to the dPAG would activate fibers of passage through this 
region, the volume of 0.2 μL does not spread in a tissue 
diameter higher than 0.4 mm in the midbrain tectum (27). 
This allowed us to assign the effects of drugs specifically 
to cell bodies of origin in the dPAG.
Experiment 1
Figure 1A and B show the mean ± SEM variation in 
freezing and escape thresholds, respectively, in response 
to electrical stimulation of the dPAG during the baseline and 
test phases in the groups of animals injected with PBS and 
spantide into the dPAG. The Student t-test showed that the 
treatments significantly increased freezing thresholds (t1,14 
= 2.34, P < 0.05) and escape thresholds (t1,14 = 2.17, P < 
0.05). Figure 1C shows that no significant effect of treat-
ments on the duration of dPAG-evoked PSF was found 
(t1,14 = 0.94, P > 0.05). The lower row in Figure 1 shows 
the variations in freezing (Figure 1D) and escape (Figure 
1E) thresholds and the duration (Figure 1F) of IC PSF. 
The freezing thresholds (t1,14 = 0.34, P > 0.05), escape 
thresholds (t1,14 = 0.67, P > 0.05), and PSF (t1,14 = 0.96, 
Figure 1. Effect of microinjections of PBS (control) and 100 pmol spantide into the dorsal periaqueductal gray (A-C) and inferior 
colliculus (D-F) of rats on freezing (A and D) and escape (B and E) thresholds. The time of post-stimulation freezing is reported 
in Panels C and F. Data are reported as means ± SEM for N = 8 rats per group. *P < 0.05 compared to control (Student t-
test).
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P > 0.05) did not differ significantly between the groups 
injected with PBS or spantide into the IC.
USVs were predominantly induced during the electrical 
stimulation of midbrain tectum structures at the freezing and 
escape thresholds. Figure 2A shows the number of 22-kHz 
calls induced by electrical stimulation of the IC in rats that 
received saline or spantide. Two-way ANOVA revealed no 
significant effects of treatment or condition on the number of 
22-kHz calls and no treatment x condition interaction (F1,28 
= 0.03, 0.01, 0.015, respectively, P > 0.05). Figure 2B shows 
the number of 22-kHz calls induced by electrical stimula-
tion of the dPAG in rats that received saline or spantide. 
Two-way ANOVA revealed significant effects of treatment 
and condition (F1,28 = 4.63 and 7.89, respectively, P < 0.05) 
on the number of calls. The treatment x condition interac-
tion was also significant (F1,28 = 4.63, P < 0.05). Post hoc 
comparisons revealed that electrical stimulation increased 
the number of USVs emitted, and intra-dPAG injections of 
spantide reduced these USV emissions. 
Experiment 2
Figure 3 shows the effects of control and 100-pmol 
spantide injections into the dPAG on exploratory activity in 
the EPM. The Student t-test showed that the treatments 
did not significantly change the number of entries into the 
open arms (t1,14 = 1.52, P > 0.05), the number of entries 
into the closed arms (t1,14 = 0.08, P > 0.05), or the time 
spent in the open arms (t1,14 = 1.44, P > 0.05).
Discussion
The present study extends the analysis of the involve-
ment of NK in defense reactions by comparing the effects 
of the NK-1 receptor antagonist spantide into the dPAG 
and IC. Substance P is involved in several behavioral 
processes, such as reinforcement, learning, memory, and 
pain (28-31). Substance P-mediated mechanisms involved 
in stress, depression-, and anxiety-related behaviors have 
recently received considerable attention (9,10). Regarding 
the neural substrates of fear and anxiety, we sought to 
investigate the extent to which NK mechanisms regulate 
the expression of fear behavior in the dPAG and IC. Sub-
stantial concentrations of substance P have been found 
in the dPAG (32), and substance P has been shown to be 
a mediator of defensive behavior. Unknown, however, is 
the extent to which these mechanisms operate in the IC, 
another structure of the brain aversion system.
Figure 2. Effects of injection of spantide into the inferior colli-
culus (A) and the dorsal periaqueductal gray (B) on the number 
of 22-kHz vocalizations (mean ± SEM) emitted during electrical 
stimulation of the midbrain tectum. N = 8 rats per group. *P < 
0.05 compared to baseline in the control group (two-way ANOVA 
followed by the Bonferroni test).
Figure 3. Effects of injections of phosphate-buffered saline (PBS) 
and 100 pmol spantide into the dorsal periaqueductal gray on the 
exploratory behavior of rats subjected to the elevated plus maze. 
A and C, Number of entries into the open and closed arms of the 
maze. B, Time spent in the open arms of the maze. Data are re-
ported as means ± SEM for N = 8 rats per group (Student t-test).
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Substance P binds to the three known NK receptors but 
has greater affinity for the NK-1 receptor (33). The obser-
vation that NK-1 receptor antagonists may be effective in 
the treatment of depression in patients with symptoms of 
anxiety has led to research efforts aimed at the develop-
ment of NK-related therapeutics for both depression and 
anxiety (9,14,34,35). Several studies have shown that the 
anxiogenic-like effects of substance P in the dPAG appear to 
be mediated by NK-1 receptors (7,8,12,13). Infusion of the 
NK-1 agonist SAR-MET-SP into the dPAG had anxiogenic-
like and antinociceptive effects in the EPM (7). These data 
suggest that NK-1 mechanisms in the dPAG are involved 
in the processing of proximal threatening stimulations or 
intense fear. NK-1 receptors appear to be involved in the 
aversive effects of substance P in the dPAG, but the role of 
NK-2 and NK-3 receptors in this region in the modulation 
of fear is still unclear. Previous studies from this laboratory 
showed that NK-1-mediated mechanisms, but not NK-3, 
are involved in the mediation of defensive behavior elicited 
by stimulation of the dPAG (22). The anti-aversive effects 
of spantide in the present study support the hypothesis 
that NK-1 receptors in the dPAG play a pro-aversive role 
and corroborate and extend the proposed involvement of 
the NK system in the modulation of defensive behavior in 
this region.
NK-1 receptors in the dPAG do not appear to be involved 
in the modulation of dPAG PSF because no effect was 
observed after spantide injections into the dPAG. Dorsal 
periaqueductal gray PSF is not a conditioned response to 
the context where electrical stimulation of the dPAG was 
administered. Previous studies from this laboratory using the 
context shift procedure have shown that freezing behavior 
persists when the animal is placed in a different context 
soon after dPAG stimulation (15,16). Post-stimulation 
freezing is regulated by mechanisms that are different from 
dPAG-evoked fear. Electrolytic lesions or muscimol-induced 
inactivation of the amygdaloid complex reduced dPAG PSF 
but did not affect dPAG-evoked freezing and escape (17,36). 
The dPAG PSF depends on an ascending path from the 
dPAG to rostral brain structures probably relayed by the 
laterodorsal nucleus of the thalamus since dPAG-evoked 
post-stimulation freezing behavior causes simultaneous 
Fos-labeling in this thalamic nucleus (for a review, see Ref. 
3). Thus, ascending dPAG efferents appear to be activated 
during this condition and the lack of change in freezing 
and escape thresholds observed in amygdala-lesioned 
or -inactivated animals may be linked to the fact that the 
dPAG itself contains neural substrates of the production of 
unconditioned fear. Thus, although dPAG-evoked freezing 
and dPAG PSF are interrelated, they appear to have differ-
ent neural substrates, similar to the differential substrates 
of dPAG-evoked freezing and escape (17,25,37). Probably, 
dPAG integrates sensory information by transmitting this 
information to the amygdala, which allows the recognition 
of threatening stimuli in fear-experienced animals.
The lack of effect of intra-IC injections of spantide on 
defense reactions induced by stimulation of this midbrain 
area needs to be discussed in the context of sensorimo-
tor gating of the defense reaction. The dPAG is generally 
recognized as an output center for defensive behavior and 
processes aversive information. Thus, whereas freezing 
and escape responses are the result of aversive stimula-
tion of this area and representative of the expression of 
the defense reaction, dPAG PSF has been related to the 
processing of aversive information in higher brain structures, 
including the amygdala. In contrast, the IC appears to be a 
part of the entire defense process in a way that is different 
from the dPAG. The IC is more involved with the sensory 
output component of the defense reaction. NK-mediated 
mechanisms do not appear to mediate this sensory com-
ponent of the defense reaction. Dorsal periaqueductal gray 
PSF and fear responses induced by electrical stimulation 
of the IC were not affected by local injections of spantide. 
These data suggest that NK-mediated mechanisms are not 
involved in the processing of ascending aversive informa-
tion from the midbrain tectum. Only the motor component 
of the defense reaction triggered by dPAG stimulation was 
sensitive to spantide injection.
NK-1 and NK-3 receptors are widely distributed in the 
brain, particularly in most limbic structures, and NK-2 recep-
tors are found only in a few structures that are not directly 
related to the integration of emotional behavior (38). NK-3 
receptors have been associated with locomotor activity, 
pain processing, and promnestic effects (22). In contrast, 
substance P and NK-1 agonists exert anxiogenic effects 
when applied locally to the dPAG (7,8,39). However, we 
found no effect of the selective NK-1 antagonist spantide 
on exploratory behavior in rats subjected to the EPM, sug-
gesting discrepant results. Intra-dPAG injections of spantide 
did not affect the conflict expressed by rats when they are 
confronted with the need to explore a novel environment and 
to avoid unknown areas, which are characteristic behaviors 
observed in this test. One possibility of reconciling this 
discrepancy is to consider that two dissociable processes 
are recruited in the EPM: i) anxiogenic stimuli associated 
with the EPM activate pathways in this region that ascend 
to higher structures of the brain aversion system, and ii) 
the height and open spaces of the EPM trigger output 
motor mechanisms of the defense reaction that exist in 
the dPAG. The former process is not mediated by NK-1 
mechanisms. The neural substrates that underlie these 
processes are responsible for the acquisition of aversive 
information. Since substance P-mediated mechanisms 
are mainly involved in the output processes related to the 
defense reaction, this may explain why spantide did not 
affect PSF-evoked freezing and did not exert any effects 
on exploratory behavior in the EPM in rats that received 
injections into the dPAG. An experiment using the EPM 
test is under way in this laboratory to examine the effects 
of injections of spantide into the IC, a structure of the brain 
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aversion system that is mainly involved in the transfer of 
aversive information to other structures and is not an output 
center for the defense reaction, in contrast to the dPAG (for 
a review, see Ref. 40). With regard to the latter process, 
NK-1 receptors modulate the defense mechanisms of the 
dPAG only when they are called into play by the presence 
of aversive stimuli, i.e., this mediation is phasic. Substance 
P may mimic the effects of anxiogenic stimuli and activates 
these neural mechanisms, but NK-1 antagonists do not 
produce any effect by their own. 5-HT mechanisms are also 
considered to modulate phasically the neural substrates 
of defense in the midbrain tectum since 5-HT receptor 
agonists counteract, but 5-HT antagonists have no effects, 
the aversion induced by stimulation of these structures (for 
a review, see Ref. 2). This is in sharp contrast to GABA 
mechanisms, which tonically modulate the descending 
pathways associated with the defensive behavior. When 
these neural mechanisms are under tonic control, GABA 
antagonists do release the defense reaction (for a review, 
see Ref. 40). Defensive responses to aversive stimulation, 
such as USVs, that are clearly mediated by these output 
mechanisms in the dPAG (20) are sensitive to the effects of 
NK-1 receptor antagonists (7). NK-1-mediated mechanisms 
operate only during the expression of the defense reaction. 
However, substantial research remains to be done to clarify 
the precise mechanism of action of these compounds and 
dissociate the processing of the defense reaction from the 
motor output of the defense reaction.
The present study extends the analysis of the involve-
ment of NK in defense reactions by comparing the effects 
of the NK-1 receptor antagonist spantide into the dPAG 
and IC. Dorsal periaqueductal gray PSF was unaffected 
by NK-1 and NK-3 drugs injected into the dPAG (22), 
suggesting that ascending aversive information from the 
dPAG to higher structures in the brain is not controlled by 
NK-mediated mechanisms. Taken together, the results from 
this laboratory support the hypothesis that NK-1 receptors 
mediate defensive behaviors induced by electrical stimula-
tion of the dPAG in rats.
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